ID   ALPK2_HUMAN             Reviewed;        2170 AA.
AC   Q86TB3; Q6ZUX0; Q8NAT5; Q96L95;
DT   28-NOV-2006, integrated into UniProtKB/Swiss-Prot.
DT   14-APR-2009, sequence version 3.
DT   05-OCT-2010, entry version 60.
DE   RecName: Full=Alpha-protein kinase 2;
DE            EC=2.7.11.-;
DE   AltName: Full=Heart alpha-protein kinase;
GN   Name=ALPK2; Synonyms=HAK;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 308-2170 (ISOFORM 1), AND VARIANTS
RP   GLN-719; SER-810; THR-825; ILE-891; LYS-916; VAL-1057; PRO-1174;
RP   SER-1449; SER-1551 AND VAL-2157.
RC   TISSUE=Skeletal muscle;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16177791; DOI=10.1038/nature03983;
RA   Nusbaum C., Zody M.C., Borowsky M.L., Kamal M., Kodira C.D.,
RA   Taylor T.D., Whittaker C.A., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Yang X., Abouelleil A., Allen N.R., Anderson S.,
RA   Bloom T., Bugalter B., Butler J., Cook A., DeCaprio D., Engels R.,
RA   Garber M., Gnirke A., Hafez N., Hall J.L., Norman C.H., Itoh T.,
RA   Jaffe D.B., Kuroki Y., Lehoczky J., Lui A., Macdonald P., Mauceli E.,
RA   Mikkelsen T.S., Naylor J.W., Nicol R., Nguyen C., Noguchi H.,
RA   O'Leary S.B., Piqani B., Smith C.L., Talamas J.A., Topham K.,
RA   Totoki Y., Toyoda A., Wain H.M., Young S.K., Zeng Q., Zimmer A.R.,
RA   Fujiyama A., Hattori M., Birren B.W., Sakaki Y., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 18.";
RL   Nature 437:551-555(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 552-1770 (ISOFORM 2), AND
RP   VARIANTS GLN-719; SER-810; THR-825; ILE-891; LYS-916; VAL-1057;
RP   PRO-1174; SER-1449 AND VAL-2157.
RC   TISSUE=Heart, and Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 569-2170 (ISOFORM 2), AND VARIANTS
RP   GLN-719; SER-810; THR-825; LYS-916; VAL-1057; ILE-1133; PRO-1174 AND
RP   SER-1449.
RX   MEDLINE=99147092; PubMed=10021370; DOI=10.1016/S0960-9822(99)80006-2;
RA   Ryazanov A.G., Pavur K.S., Dorovkov M.V.;
RT   "Alpha-kinases: a new class of protein kinases with a novel catalytic
RT   domain.";
RL   Curr. Biol. 9:R43-R45(1999).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1602, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18187866; DOI=10.2116/analsci.24.161;
RA   Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.;
RT   "Automated phosphoproteome analysis for cultured cancer cells by two-
RT   dimensional nanoLC-MS using a calcined titania/C18 biphasic column.";
RL   Anal. Sci. 24:161-166(2008).
RN   [6]
RP   VARIANTS [LARGE SCALE ANALYSIS] LYS-942 AND THR-1476.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Kinases that recognize phosphorylation sites in which
CC       the surrounding peptides have an alpha-helical conformation.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q86TB3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q86TB3-2; Sequence=VSP_036887;
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Alpha-type
CC       protein kinase family. ALPK subfamily.
CC   -!- SIMILARITY: Contains 1 alpha-type protein kinase domain.
CC   -!- SIMILARITY: Contains 2 Ig-like (immunoglobulin-like) domains.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAK95952.1; Type=Erroneous initiation;
CC       Sequence=BAC03812.1; Type=Erroneous initiation;
CC       Sequence=CAD89922.1; Type=Erroneous initiation;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL832018; CAD89922.1; ALT_INIT; mRNA.
DR   EMBL; BX647796; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BX647639; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AK092133; BAC03812.1; ALT_INIT; mRNA.
DR   EMBL; AY044450; AAK95952.1; ALT_INIT; mRNA.
DR   IPI; IPI00646010; -.
DR   IPI; IPI00792557; -.
DR   RefSeq; NP_443179.3; -.
DR   UniGene; Hs.628152; -.
DR   HSSP; Q923J1; 1IAJ.
DR   ProteinModelPortal; Q86TB3; -.
DR   STRING; Q86TB3; -.
DR   PhosphoSite; Q86TB3; -.
DR   PRIDE; Q86TB3; -.
DR   Ensembl; ENST00000361673; ENSP00000354991; ENSG00000198796.
DR   GeneID; 115701; -.
DR   KEGG; hsa:115701; -.
DR   UCSC; uc002lhj.2; human.
DR   CTD; 115701; -.
DR   GeneCards; GC18M056148; -.
DR   H-InvDB; HIX0014477; -.
DR   HGNC; HGNC:20565; ALPK2.
DR   HPA; HPA027377; -.
DR   HPA; HPA027976; -.
DR   HPA; HPA028084; -.
DR   HPA; HPA029801; -.
DR   PharmGKB; PA134916108; -.
DR   eggNOG; prNOG10203; -.
DR   HOGENOM; HBG282637; -.
DR   HOVERGEN; HBG100440; -.
DR   InParanoid; Q86TB3; -.
DR   OMA; AILQVPC; -.
DR   OrthoDB; EOG9BCH6J; -.
DR   ArrayExpress; Q86TB3; -.
DR   Bgee; Q86TB3; -.
DR   CleanEx; HS_ALPK2; -.
DR   Genevestigator; Q86TB3; -.
DR   GermOnline; ENSG00000198796; Homo sapiens.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IEA:InterPro.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR004166; MHCK_EF2_kinase.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 2.
DR   Pfam; PF02816; Alpha_kinase; 1.
DR   Pfam; PF07679; I-set; 2.
DR   SMART; SM00811; Alpha_kinase; 1.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00408; IGc2; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS51158; ALPHA_KINASE; 1.
DR   PROSITE; PS50835; IG_LIKE; 2.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Disulfide bond;
KW   Immunoglobulin domain; Kinase; Phosphoprotein; Polymorphism; Repeat;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1   2170       Alpha-protein kinase 2.
FT                                /FTId=PRO_0000260030.
FT   DOMAIN       10    114       Ig-like 1.
FT   DOMAIN     1786   1874       Ig-like 2.
FT   DOMAIN     1901   2133       Alpha-type protein kinase.
FT   COMPBIAS   1644   1649       Poly-Ser.
FT   MOD_RES    1602   1602       Phosphoserine.
FT   DISULFID     33     98       By similarity.
FT   DISULFID   1808   1858       By similarity.
FT   VAR_SEQ    1006   1010       Missing (in isoform 2).
FT                                /FTId=VSP_036887.
FT   VARIANT       2      2       K -> T (in dbSNP:rs6566987).
FT                                /FTId=VAR_054914.
FT   VARIANT     136    136       R -> S (in dbSNP:rs9944810).
FT                                /FTId=VAR_054915.
FT   VARIANT     719    719       H -> Q (in dbSNP:rs12103986).
FT                                /FTId=VAR_054916.
FT   VARIANT     810    810       G -> S (in dbSNP:rs3809970).
FT                                /FTId=VAR_054917.
FT   VARIANT     825    825       R -> T (in dbSNP:rs3809972).
FT                                /FTId=VAR_054918.
FT   VARIANT     829    829       K -> N (in dbSNP:rs3809973).
FT                                /FTId=VAR_054919.
FT   VARIANT     884    884       S -> L (in dbSNP:rs3809974).
FT                                /FTId=VAR_054920.
FT   VARIANT     891    891       T -> I (in dbSNP:rs3826593).
FT                                /FTId=VAR_054921.
FT   VARIANT     916    916       N -> K (in dbSNP:rs4940404).
FT                                /FTId=VAR_054922.
FT   VARIANT     942    942       E -> K (in an ovarian undifferentiated
FT                                carcinoma sample; somatic mutation).
FT                                /FTId=VAR_045591.
FT   VARIANT     977    977       S -> T (in dbSNP:rs3809975).
FT                                /FTId=VAR_054923.
FT   VARIANT    1057   1057       L -> V (in dbSNP:rs3809976).
FT                                /FTId=VAR_054924.
FT   VARIANT    1063   1063       G -> V (in dbSNP:rs34347938).
FT                                /FTId=VAR_062168.
FT   VARIANT    1133   1133       T -> I (in dbSNP:rs3826593).
FT                                /FTId=VAR_045592.
FT   VARIANT    1134   1134       K -> N (in dbSNP:rs35791514).
FT                                /FTId=VAR_054925.
FT   VARIANT    1174   1174       H -> P (in dbSNP:rs3809977).
FT                                /FTId=VAR_054926.
FT   VARIANT    1296   1296       L -> V (in dbSNP:rs3809976).
FT                                /FTId=VAR_045593.
FT   VARIANT    1449   1449       P -> S (in dbSNP:rs3809982).
FT                                /FTId=VAR_054927.
FT   VARIANT    1476   1476       K -> T (in a melanoma metastatic sample;
FT                                somatic mutation).
FT                                /FTId=VAR_045594.
FT   VARIANT    1551   1551       A -> S (in dbSNP:rs3809983).
FT                                /FTId=VAR_054928.
FT   VARIANT    1579   1579       Q -> R (in dbSNP:rs33910491).
FT                                /FTId=VAR_054929.
FT   VARIANT    1729   1729       K -> E (in dbSNP:rs34409558).
FT                                /FTId=VAR_054930.
FT   VARIANT    1730   1730       K -> E (in dbSNP:rs17065127).
FT                                /FTId=VAR_054931.
FT   VARIANT    1767   1767       H -> Y (in dbSNP:rs7234999).
FT                                /FTId=VAR_054932.
FT   VARIANT    1884   1884       R -> C (in dbSNP:rs33969768).
FT                                /FTId=VAR_057742.
FT   VARIANT    1969   1969       E -> K (in dbSNP:rs17065127).
FT                                /FTId=VAR_045595.
FT   VARIANT    2157   2157       I -> V (in dbSNP:rs7240666).
FT                                /FTId=VAR_054933.
FT   CONFLICT    550    550       N -> S (in Ref. 1; BX647796).
FT   CONFLICT    829    829       K -> S (in Ref. 1; CAD89922).
FT   CONFLICT    912    912       A -> T (in Ref. 1; BX647796).
FT   CONFLICT    959    959       G -> E (in Ref. 4; BAC03812).
FT   CONFLICT   1067   1067       K -> E (in Ref. 1; CAD89922).
FT   CONFLICT   1165   1165       E -> G (in Ref. 1; CAD89922).
FT   CONFLICT   1217   1217       I -> T (in Ref. 4; BAC03812).
FT   CONFLICT   1402   1402       S -> P (in Ref. 1; BX647796).
FT   CONFLICT   1428   1428       Q -> R (in Ref. 4; BAC03812).
FT   CONFLICT   1443   1443       H -> R (in Ref. 1; BX647796).
FT   CONFLICT   1784   1784       R -> S (in Ref. 1; BX647639).
FT   CONFLICT   1814   1814       H -> R (in Ref. 1; BX647796).
FT   CONFLICT   1939   1939       M -> V (in Ref. 1; CAD89922).
FT   CONFLICT   2042   2042       I -> V (in Ref. 1; CAD89922).
FT   CONFLICT   2092   2092       G -> D (in Ref. 1; BX647796).
SQ   SEQUENCE   2170 AA;  237013 MW;  5C257153F091B08E CRC64;
     MKDSEGPQRP PLCFLSTLLS QKVPEKSDAV LRCIISGQPK PEVTWYKNGQ AIDGSGIISN
     YEFFENQYIH VLHLSCCTKN DAAVYQISAK NSFGMICCSA SVEVECSSEN PQLSPNLEDD
     RDRGWKHETG THEEERANQI DEKEHPYKEE ESISPGTPRS ADSSPSKSNH SLSLQSLGNL
     DISVSSSENP LGVKGTRHTG EAYDPSNTEE IANGLLFLNS SHIYEKQDRC CHKTVHSMAS
     KFTDGDLNND GPHDEGLRSS QQNPKVQKYI SFSLPLSEAT AHIYPGDSAV ANKQPSPQLS
     SEDSDSDYEL CPEITLTYTE EFSDDDLEYL ECSDVMTDYS NAVWQRNLLG TEHVFLLESD
     DEEMEFGEHC LGGCEHFLSG MGCGSRVSGD AGPMVATAGF CGHHSQPQEV GVRSSRVSKH
     GPSSPQTGMT LILGPHQDGT SSVTEQGRYK LPTAPEAAEN DYPGIQGETR DSHQAREEFA
     SDNLLNMDES VRETEMKLLS GESENSGMSQ CWETAADKRV GGKDLWSKRG SRKSARVRQP
     GMKGNPKKPN ANLRESTTEG TLHLCSAKES AEPPLTQSDK RETSHTTAAA TGRSSHADAR
     ECAISTQAEQ EAKTLQTSTD SVSKEGNTNC KGEGMQVNTL FETSQVPDWS DPPQVQVQET
     VRETISCSQM PAFSEPAGEE SPFTGTTTIS FSNLGGVHKE NASLAQHSEV KPCTCGPQHE
     EKQDRDGNIP DNFREDLKYE QSISEANDET MSPGVFSRHL PKDARADFRE PVAVSVASPE
     PTDTALTLEN VCDEPRDREA VCAMECFEAG DQGTCFDTID SLVGRPVDKY SPQEICSVDT
     ELAEGQNKVS DLCSSNDKTL EVFFQTQVSE TSVSTCKSSK DGNSVMSPLF TSTFTLNISH
     TASEGATGEN LAKVENSTYP LASTVHAGQE QPSPSNSGGL DETQLLSSEN NPLVQFKEGG
     DKSPSPSAAD TTATPASYSS IVSFPWEKPT TLTANNECFQ ATRETEDTST VTIATEVHPA
     KYLAVSIPED KHAGGTEERF PRASHEKVSQ FPSQVQLDHI LSGATIKSTK ELLCRAPSVP
     GVPHHVLQLP EGEGFCSNSP LQVDNLSGDK SQTVDRADFR SYEENFQERG SETKQGVQQQ
     SLSQQGSLSA PDFQQSLPTT SAAQEERNLV PTAHSPASSR EGAGQRSGWG TRVSVVAETA
     GEEDSQALSN VPSLSDILLE ESKEYRPGNW EAGNKLKIIT LEASASEIWP PRQLTNSESK
     ASDGGLIIPD KVWAVPDSLK ADAVVPELAP SEIAALAHSP EDAESALADS RESHKGEEPT
     ISVHWRSLSS RGFSQPRLLE SSVDPVDEKE LSVTDSLSAA SETGGKENVN NVSQDQEEKQ
     LKMDHTAFFK KFLTCPKILE SSVDPIDEIS VIEYTRAGKP EPSETTPQGA REGGQSNDGN
     MGHEAEIQPA ILQVPCLQGT ILSENRISRS QEGSMKQEAE QIQPEEAKTA IWQVLQPSEG
     GERIPSGCSI GQIQESSDGS LGEAEQSKKD KAELISPTSP LSSCLPIMTH ASLGVDTHNS
     TGQIHDVPEN DIVEPRKRQY VFPVSQKRGT IENERGKPLP SSPDLTRFPC TSSPEGNVTD
     FLISHKMEEP KIEVLQIGET KPPSSSSSSA KTLAFISGER ELEKAPKLLQ DPCQKGTLGC
     AKKSREREKS LEARAGKSPG TLTAVTGSEE VKRKPEAPGS GHLAEGVKKK ILSRVAALRL
     KLEEKENIRK NSAFLKKMPK LETSLSHTEE KQDPKKPSCK REGRAPVLLK KIQAEMFPEH
     SGNVKLSCQF AEIHEDSTIC WTKDSKSIAQ VQRSAGDNST VSFAIVQASP KDQGLYYCCI
     KNSYGKVTAE FNLTAEVLKQ LSSRQDTKGC EEIEFSQLIF KEDFLHDSYF GGRLRGQIAT
     EELHFGEGVH RKAFRSTVMH GLMPVFKPGH ACVLKVHNAI AYGTRNNDEL IQRNYKLAAQ
     ECYVQNTARY YAKIYAAEAQ PLEGFGEVPE IIPIFLIHRP ENNIPYATVE EELIGEFVKY
     SIRDGKEINF LRRESEAGQK CCTFQHWVYQ KTSGCLLVTD MQGVGMKLTD VGIATLAKGY
     KGFKGNCSMT FIDQFKALHQ CNKYCKMLGL KSLQNNNQKQ KQPSIGKSKV QTNSMTIKKA
     GPETPGEKKT
//
